Cite
HARVARD Citation
Telli, T. et al. (2023). Prognostic factors of overall and prostate‐specific antigen‐progression‐free survival in metastatic castration‐resistant prostate cancer patients treated with 177Lu‐PSMA‐617. A single‐center prospective observational study. Prostate. 83 (8), pp. 792-800. [Online].